Table 4 Selected cytokines and their correlations with cholesterol subfractions in healthy controls after controlling for age, BMI and gender (*p < 0.05, **p < 0.01, and ***p < 0.001)
From: Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?
Controls | IL-1β | IL-2 | IL-4 | IL-5 | IL-6 | IL-7 | IL-8 | IL-10 | IL-12 | IL-13 | IL-17 | G-CSF | GM-CSF | IFN-γ | TNF-α |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
VLDL (mg/dl) | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | −0.571 * | NS | NS |
IDL-A (mg/dl) | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
IDL-B (mg/dl) | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
IDL-C (mg/dl) | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | −0.715 ** | NS | NS |
LDL1 (mg/dl) | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
LDL2 (mg/dl) | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
LDL1–2 (mg/dl) | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
LDL3–7 (mg/dl) | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
L-HDL (mg/dl) | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | −0.819*** | NS | NS |
I-HDL (mg/dl) | NS | NS | NS | NS | NS | −0.545 * | NS | NS | NS | NS | NS | NS | NS | NS | NS |
S-HDL (mg/dl) | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
Total HDL (mg/dl) | NS | NS | NS | NS | NS | −0.582 * | NS | NS | NS | NS | NS | −0.570 * | −0.866*** | NS | NS |
Total cholesterol (mg/dl) | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | −0.659 ** | NS | NS |